Case | HBS Case Collection | 1992 (Revised from original version)

Eli Lilly and Co. (A): Globalization

by Michael Y. Yoshino
 

Abstract

Examines the changes taking place in Eli Lilly in response to the globalization of the pharmaceuticals industry. Identifies the steps taken by management, problems currently faced, and challenges for the future. Allows examination of the process of implementing a global strategy from the headquarters perspective.

Keywords: Change; Globalization; Global Strategy; Business or Company Management; Problems and Challenges; Perspective; Pharmaceutical Industry;

Format: Print 29 pages Purchase

Citation:

Yoshino, Michael Y. "Eli Lilly and Co. (A): Globalization." Harvard Business School Case 391-032, January 1992. (Revised from original September 1990 version.)

Related Work

  1. Case | HBS Case Collection | 1992 (Revised from original version)

    Eli Lilly and Co. (B): Europe

    Michael Y. Yoshino

    Examines the challenges facing the company in light of the changing economic, regulatory, and competitive environment in the European pharmaceutical industry. Examines the steps taken by the company adapting to this changing situation as part of a total globalization strategy and aggressive growth objectives in the region. Allows examination of the changing roles of country, regional, and headquarters management.

    Keywords: Change Management; Economics; Global Strategy; Business or Company Management; Growth and Development Strategy; Adaptation; Competition; Pharmaceutical Industry; Europe;

    Citation:

    Yoshino, Michael Y. "Eli Lilly and Co. (B): Europe." Harvard Business School Case 391-033, January 1992. (Revised from original August 1990 version.)
    CiteView DetailsPurchase Related

  2. Case | HBS Case Collection | 1991 (Revised from original 1990 version)

    Eli Lilly and Co. (C): Japan

    Michael Y. Yoshino

    Describes the process of establishing an independent operation in Japan in the mid-1980s as a result of a decision to make a major investment in the market. Describes the challenges in setting up such an operation and focuses on the role of the country manager in managing for rapid growth in a complex but key market.

    Keywords: Business Divisions; Business Startups; Decisions; Investment; Growth Management; Managerial Roles; Markets; Problems and Challenges; Pharmaceutical Industry; Japan;

    Citation:

    Yoshino, Michael Y. "Eli Lilly and Co. (C): Japan." Harvard Business School Case 391-034, March 1991. (Revised from original August 1990 version.)
    CiteView DetailsPurchase Related

About the Author

Photo
Michael Y. Yoshino
Herman C. Krannert Professor of Business Administration, Emeritus

View Profile »
View Publications »

 
Resources
Contact Related Links Resources